opiranserin inntooltip international nonproprietary name developmental code name selective combined glycine transporter blocker halfmaximal inhibitory concentration μm purine receptor antagonist μm serotonin receptor antagonist halfmaximal inhibitory concentration μm development vivozon intravenous treatment postoperative april phase ii clinical trials inntooltip international nonproprietary name drug issued httpsenwikipediaorgwikiopiranserin